Trials / Withdrawn
WithdrawnNCT05321953
The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation
The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Constipation Outcome Scores In Individuals With Chronic Constipation Who Plateau or Are Non- Responders to Biofeedback Therapy: A Call to Treat Beyond The Pelvic Floor
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this study will be to determine if the addition of aerobic interval and inspiratory muscle training (IMT) targeted at improving cardiopulmonary-based measures will further improve patient satisfaction scores in individuals with chronic constipation (CC) who report plateau or limited improvements in CC after demonstrating a corrected defecation pattern using anorectal biofeedback training.
Conditions
- Constipation
- Constipation by Outlet Obstruction
- Constipation-predominant Irritable Bowel Syndrome
- Constipation - Functional
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard Physical Therapy Care | Standard physical therapy care. Six to eight, one hour sessions over the course of 4-6 weeks. For individuals with chronic constipation that includes biofeedback therapy, breathing techniques on the toilet, manual therapy to the abdominal wall, and education on toileting posture and favorable lifestyle habits for gut health. |
| OTHER | Aerobic and Inspiratory Muscle Training | The exercise-based 3 times per week for 8 weeks intervention will consist of aerobic interval training and inspiratory muscle training (IMT) for a total duration of 30 minutes. Aerobic-based intervals will be performed at a moderate intensity. Aerobic modes of exercise will include upper extremity ergometer, treadmill, bike, or elliptical. |
Timeline
- Start date
- 2022-05-26
- Primary completion
- 2023-05-10
- Completion
- 2023-05-10
- First posted
- 2022-04-11
- Last updated
- 2023-05-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05321953. Inclusion in this directory is not an endorsement.